Healthcare >> CEO Interviews >> September 30, 1999
PAUL V. MAIER is Senior Vice President and Chief Financial Officer of
Ligand Pharmaceuticals Incorporated He joined Ligand in October 1992 as
Vice President and CFO. Prior to joining Ligand, Mr. Maier served as
Vice President, Finance at DFS West, a division of DFS Group, LP, a
private multinational retailer. From February 1990 to October 1990, Mr.
Maier served as Vice President and Treasurer of ICN Pharmaceuticals,
Inc., a pharmaceutical and biotechnology research products company. Mr.
Maier held various positions in finance and administration at SPI
Pharmaceuticals, Inc., a publicly held subsidiary of ICN Pharmaceuticals
Group, from 1984 to 1988, including Vice President, Finance from
February 1984 to February 1987. Mr. Maier received an MBA from Harvard
Graduate School of Business and a BS from Pennsylvania State University. Profile
TWST: Please give a brief overview and history of LigandPharmaceuticals.
Mr. Maier: Ligand Pharmaceuticals was formed with its current technology
in 1989. The technology, which involves